Author:
Mendonca Eneida,Tachinardi Umberto
Publisher
Springer International Publishing
Reference43 articles.
1. Sertkaya A, Birkenbach A, Berlind A, Eyraud J. Examination of clinical trial costs and barriers for drug development. Washington, DC: US Department of Health and Human Services; 2014.
2. Bennani YL. Drug discovery in the next decade: innovation needed ASAP. Drug Discov Today [Internet]. 2011;16:779–92.
https://www.sciencedirect.com/science/article/pii/S1359644611001826?via%3Dihub
.
3. Vallance P. Developing an open relationship with the drug industry. Lancet [Internet]. 2005;366:1062–4.
https://www.sciencedirect.com/science/article/pii/S0140673605668353?via%3Dihub
.
4. Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R & D efficiency. Nat Rev Drug Discov [Internet]. 2012;11:191–200.
http://www.ncbi.nlm.nih.gov/pubmed/22378269
.
5. Cesana BM, Biganzoli EM. Phase IV Studies: some insights, clarifications, and issues. Curr Clin Pharmacol [Internet]. 2018;13:14–20.
http://www.eurekaselect.com/161232/article
.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献